NorthPalm Capital Corp a technology company, holds ownership in various businesses and technologies from the fields of digital health, cybersecurity, biotech, and artificial intelligence. The company offers Cybeats, a supply chain cybersecurity; Fionet platform, a mobile software for delivering primary healthcare at the community level;and Raidian, an AI government platform, to enhance AI safety and trustworthiness for enterprises that are managing multiple AI systems and provide management tools for compliance with impending AI regulation. The company was formerly known as Scryb Inc. and changed its name to NorthPalm Capital Corp in April 2026. Scryb Inc. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does Scythian Biosciences Corp (SCYB) operate in?
Scythian Biosciences Corp belongs to the Information Technology sector and operates in the Software - Infrastructure industry.
What is Scythian Biosciences Corp (SCYB) current stock price?
As of the latest data, Scythian Biosciences Corp stock price is CA$0.11, with a previous close of CA$0.11.
What is Scythian Biosciences Corp (SCYB) current market capitalization?
Scythian Biosciences Corp market cap is approximately 4.94 million.
What is Scythian Biosciences Corp (SCYB) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.24.
Does Scythian Biosciences Corp (SCYB) pay dividends?
No. Scythian Biosciences Corp does not pay a dividend.
What is Scythian Biosciences Corp (SCYB) beta (volatility) score?
Scythian Biosciences Corp has a beta of -0.217, indicating lower volatility than the overall market.
